What Causes Heart Palpitations in PMDD?

What Causes Heart Palpitations in PMDD?

Yes, PMDD can directly cause heart palpitations. The primary driver is the steep drop in progesterone and estrogen in the late luteal phase, which destabilizes the autonomic nervous system (ANS) and raises sympathetic tone — producing racing, fluttering, or skipped beats. The main caveat: if palpitations persist through the entire cycle, an independent cardiac or thyroid cause should be ruled out first.

---

Why Hormones Trigger Heart Rhythm Changes

The connection between reproductive hormones and cardiac rhythm is well-established in the medical literature, even if it rarely comes up in a gynecology appointment.

Estrogen has direct electrophysiological effects on the heart. It modulates ion channels — particularly sodium, potassium, and calcium channels — that control the timing of each heartbeat (Bidoggia et al., Journal of the American College of Cardiology 2000; PMID: 11073877). When estrogen falls sharply in the late luteal phase, those channels become temporarily less stable, increasing the likelihood of ectopic beats (extra or misfired heartbeats that feel like a "flip" in the chest).

Progesterone's role is more indirect but equally important. It acts on GABA-A receptors through its metabolite allopregnanolone. In the luteal phase, allopregnanolone rises and creates a calming, almost sedative tone on the central nervous system. When progesterone crashes before menstruation, allopregnanolone withdrawal mimics a low-grade benzodiazepine withdrawal — anxiety spikes, the sympathetic nervous system accelerates, and the heart rate becomes erratic (Bäckström et al., Epilepsia 2011; PMID: 21929535).

This combination — disrupted cardiac ion channels plus elevated sympathetic drive — explains why palpitations in PMDD cluster so reliably in the five to ten days before menstruation and resolve within one to two days of bleeding.

The autonomic nervous system piece matters most. Heart rate variability (HRV) studies show measurably lower parasympathetic (rest-and-digest) activity during the luteal phase in women with PMDD compared to controls, meaning their hearts are genuinely running hotter and less rhythmically during that window (Girdler et al., Psychosomatic Medicine 1998; PMID: 9879035).

---

The Magnesium Connection in PMDD

One underappreciated driver of luteal-phase palpitations is magnesium depletion. Magnesium is required for the Na/K-ATPase pump that maintains electrical stability across cardiac cell membranes. When intracellular magnesium is low, the threshold for ectopic beats drops.

Women with PMDD have been shown to have significantly lower red blood cell magnesium levels compared to women without PMS during the luteal phase (Rosenstein et al., American Journal of Obstetrics and Gynecology 1994; PMID: 8116279). Estrogen fluctuations increase urinary magnesium excretion, and the typical high-stress, high-caffeine lifestyle that worsens PMDD further depletes it. The result is a cyclical deficiency that amplifies both mood symptoms and cardiac irritability in the same two-week window.

This is also why caffeine and alcohol — both magnesium-depleting compounds — often trigger noticeably worse palpitations premenstrually than at other times of the month.

---

What Causes Heart Palpitations in Perimenopause?

Perimenopause — the transition period that typically begins in the mid-to-late 40s — shares significant mechanistic overlap with PMDD, which is why women who were symptomatic premenstrually often find their palpitations worsen dramatically during this phase.

In perimenopause, estrogen levels do not decline linearly. Instead, they swing erratically: some cycles produce very high estrogen surges (driven by the ovaries working harder to compensate for declining follicle reserves), while others produce crashes. These unpredictable surges and withdrawals create the same ion-channel instability described above, but with greater amplitude and less predictability than the monthly PMDD pattern.

Palpitations in perimenopause are common enough that the North American Menopause Society recognizes them as a core vasomotor symptom cluster alongside hot flashes and night sweats. The hot flash itself can trigger a palpitation — the sudden peripheral vasodilation produces a reflex increase in heart rate that some women experience as a flutter or racing sensation.

If you're tracking biomarkers, elevated high-sensitivity CRP during perimenopausal transitions has been associated with increased cardiovascular risk that goes beyond palpitations alone — understanding what causes high CRP is worth adding to your workup if palpitations are frequent.

---

What Causes Heart Palpitations in Menopause?

Natural menopause (defined as 12 consecutive months without a period) brings estrogen to a chronically low baseline rather than the dramatic swings of perimenopause. For many women, palpitations actually improve post-transition for this reason. However, a subset continues to experience them — and in this group, the mechanisms shift.

At low estrogen, the sympathetic nervous system becomes chronically upregulated. Basal norepinephrine levels are higher in postmenopausal women than in premenopausal women (Mercuro et al., American Journal of Cardiology 2000), reflecting a tonic increase in sympathetic tone that predisposes to faster heart rates and occasional palpitations even without a hormonal trigger.

Second, the loss of estrogen's anti-inflammatory and endothelial-protective effects means the cardiovascular system as a whole is operating in a more vulnerable state. Elevated LDL particle counts and triglycerides are common companions to menopause — and what causes triglycerides to be out of range is increasingly relevant for women navigating this hormonal shift, because dyslipidemia can independently stress the cardiac conduction system.

Thyroid dysfunction also becomes more prevalent after menopause. Subclinical hyperthyroidism — even a TSH at the low end of normal — is a recognized cause of persistent palpitations that is frequently missed because TSH is not always checked when palpitations are attributed to menopause.

---

What Causes Heart Palpitations After a Hysterectomy?

A hysterectomy that preserves the ovaries typically causes a temporary hormonal disruption due to reduced blood flow to the ovaries post-surgery, but the ovaries continue producing estrogen and progesterone — palpitations in this scenario usually resolve within weeks to months.

A hysterectomy with bilateral oophorectomy (removal of both ovaries) is a different physiological event. It induces surgical menopause instantly, regardless of the woman's age. The estrogen drop is abrupt rather than gradual, and the autonomic nervous system has no time to adapt. This produces a sharp increase in sympathetic tone that can cause significant palpitations, hot flashes, and sleep disruption within days of surgery.

Women who undergo surgical menopause before natural menopause age face compounded cardiovascular risk: the abrupt loss of estrogen's cardioprotective effects accelerates arterial stiffening and can alter the lipid panel substantially. Monitoring ApoB levels after a hysterectomy is something functional medicine practitioners increasingly recommend, because ApoB is a more sensitive marker of atherogenic risk than standard LDL in this population.

---

What Causes Heart Palpitations in Postmenopause?

In the postmenopausal years — typically five or more years after the final period — palpitations that arise for the first time deserve careful evaluation rather than automatic attribution to hormones. The estrogen decline is now stable, so new palpitations in this phase are more likely to reflect:

• Structural changes: Left ventricular hypertrophy from chronically elevated blood pressure (more common post-menopause)
• Atrial fibrillation: Incidence rises steeply with age and is more common in women with prior hormonal disruptions
• Thyroid dysfunction: Particularly subclinical hyperthyroidism or Graves' disease
• Electrolyte imbalances: Low potassium or magnesium from diuretic use, common in this age group
• Sleep apnea: Strongly associated with nocturnal palpitations; often undiagnosed in postmenopausal women

Homocysteine elevation is another underrecognized contributor to cardiac rhythm disturbances in older women — it promotes vascular inflammation and oxidative stress that can irritate the conduction system. What causes homocysteine to be out of range is a relevant read for anyone experiencing unexplained cardiovascular symptoms after menopause.

---

When to Seek Immediate Evaluation

Most PMDD-related palpitations are benign ectopic beats — uncomfortable but not dangerous. Seek prompt evaluation if you experience:

• Palpitations accompanied by chest pain, pressure, or shortness of breath
• Palpitations that cause dizziness, presyncope, or fainting
• Palpitations that are rapid, regular, and last more than 30 seconds
• Palpitations that occur outside the luteal phase consistently
• A family history of sudden cardiac death or arrhythmia

A 24-hour Holter monitor or a 14-day event monitor can capture the rhythm during a symptomatic episode and definitively classify the arrhythmia.

---

What This Means for Your Formula

For women navigating PMDD-related palpitations, the supplement strategy centers on three interconnected priorities: restoring magnesium status, modulating the stress axis that amplifies luteal-phase autonomic instability, and supporting cardiovascular electrical stability.

Magnesium Glycinate is the first-line consideration. Unlike magnesium oxide, glycinate is highly bioavailable and well-tolerated at the therapeutic doses needed to raise intracellular magnesium. Ones includes magnesium glycinate in its Magnesium Complex blend, formulated to deliver clinically relevant elemental magnesium without the laxative effect of cheaper forms.

Ashwagandha (KSM-66, 600 mg) addresses the sympathetic overdrive component. A 2019 randomized controlled trial in stressed adults found KSM-66 at 600 mg daily significantly reduced serum cortisol and self-reported stress scores over 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Because the autonomic nervous system instability in PMDD is HPA-axis-mediated as well as hormone-mediated, an adaptogen with strong cortisol-lowering evidence is mechanistically relevant — not just a generic stress add-on.

Omega-3 (EPA/DHA) supports cardiac rhythm stability through multiple pathways: reducing inflammatory cytokines that irritate the conduction system, improving heart rate variability, and modulating the same ion channels that estrogen fluctuations disrupt. Meta-analyses support EPA/DHA for reducing ventricular ectopy and improving HRV in cardiovascular populations.

At Ones, your formula is not self-selected from a catalog — the AI practitioner analyzes your lab results, wearable HRV data, and symptom history to determine which of these ingredients you actually need and at what dose, within a 6 or 9-capsule daily plan. The result is a formula calibrated to your hormonal and cardiovascular picture, not a generic women's health blend.

---

Key Takeaways

• PMDD palpitations are mechanistically driven by estrogen and progesterone withdrawal that destabilizes cardiac ion channels and elevates sympathetic nervous system tone in the luteal phase.
• Allopregnanolone withdrawal — the progesterone metabolite that calms GABA receptors — is a major trigger for the anxiety and autonomic hyperactivity that underlies palpitations.
• Magnesium deficiency is common in PMDD and lowers the threshold for ectopic beats; luteal-phase depletion is partly hormonal, not purely dietary.
• Perimenopause amplifies PMDD patterns due to erratic estrogen surges, while post-menopausal palpitations warrant a broader cardiac workup.
• Surgical menopause (oophorectomy) produces abrupt sympathetic activation and deserves the same cardiovascular monitoring as natural menopause — often faster.
• Persistent, non-cyclical, or severe palpitations should always be evaluated with cardiac monitoring before attributing them to hormones alone.